CAY10505
- CAS No.
- 1218777-13-9
- Chemical Name:
- CAY10505
- Synonyms
- CAY10505;CAY10505, >=98%;CAY10505 ,S2682;CAY10505 CAY-10505;CAY10505 USP/EP/BP;CAY10505, 10 mM in DMSO;(E)-5-((5-(4-fluorophenyl)furan-2-yl)methylene)thiazolidine-2,4-dione;(5E)-5-[[5-(4-Fluorophenyl)-2-furanyl]methylene]-2,4-thiazolidinedione;2,4-Thiazolidinedione, 5-[[5-(4-fluorophenyl)-2-furanyl]methylene]-, (5E)-;CAY10505 ( 5E)-5-[[5-(4-Fluorophenyl)-2-furanyl]methylene]-2,4-thiazolidinedione
- CBNumber:
- CB72561463
- Molecular Formula:
- C14H8FNO3S
- Molecular Weight:
- 289.28
- MDL Number:
- MFCD00640727
- MOL File:
- 1218777-13-9.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Density | 1.466 |
|---|---|
| storage temp. | Store at -20°C |
| solubility | insoluble in EtOH; insoluble in H2O; ≥14.45 mg/mL in DMSO |
| form | solid |
| pka | 7.21±0.20(Predicted) |
| color | Light yellow to yellow |
| FDA UNII | S8TQU87RAT |
CAY10505 price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| ChemScene | CS-5662 | CAY10505 98.01% | 1218777-13-9 | 10mg | $43 | 2026-06-04 | Buy |
| ChemScene | CS-5662 | CAY10505 98.01% | 1218777-13-9 | 25mg | $70 | 2026-06-04 | Buy |
| ChemScene | CS-5662 | CAY10505 98.01% | 1218777-13-9 | 50mg | $125 | 2026-06-04 | Buy |
| ChemScene | CS-5662 | CAY10505 98.01% | 1218777-13-9 | 100mg | $206 | 2026-06-04 | Buy |
| ApexBio Technology | B2182 | CAY10505 | 1218777-13-9 | EvaluationSample | $30 | 2026-05-06 | Buy |
CAY10505 Chemical Properties,Uses,Production
Uses
CAY10505 is a phosphoinositide 3-kinase gamma (PI3Kγ) specific inhibitor and improves hypertension-associated vascular endothelial dysfunction.
Biological Activity
cay10505 is a potent and selective pi3kγ inhibitor (ic50= 30 nm)pi3k (phosphatidylinositol-4,5-bisphosphate 3-kinase) is a family of enzymes involved in cellular functions such as cell growth, proliferation, differentiation, motility, survival and intracellular trafficking, which in turn are involved in cancer. it plays a key role in pi3k/akt/mtor pathway.in neurons treated with 3.5 μm ba, 200 nm cay10505 partially reduced the baicalein-induced akt phosphorylation. [1]in hypertensive rats, cay10505 at 0.6 mg.kg-1 p.o. exhibited the following effects 1) effectively reduced mabp; 2) significantly ameliorated vascular endothelium dysfunction in hypertensive rats in combination of doca; 3) prominently increased serum nitrite and/or nitrate concentrations.4) prevented hypertension-induced attenuation of ach-induced endothelium-dependent relaxation.[2]
in vivo
Administration of CAY10505 (0.6 mg/kg, p.o.), Losartan (25 mg/kg, p.o.), or Atorvastatin (30 mg/kg, p.o.) significantly increases serum nitrite and (or) nitrate concentrations in hypertensive rats. Acetylcholine (ACh) and Sodium nitroprusside (SNP) produce endothelium-dependent and-independent relaxation in isolated rat aortic ring precontracted with Phenylephrine (3 μM), in a dose dependent manner. Administration of CAY10505 (0.6 mg/kg,p.o.), Losartan (25 mg/kg, p.o.), or Atorvastatin (30 mg/kg, p.o.) significantly prevents hypertension-induced attenuation of ACh-induced endothelium-dependent relaxation. Deoxycorticosterone acetate salt (DOCA, 40 mg/kg, s.c.) induced hypertension markedly attenuates acetylcholine-induced endothelium-dependent relaxation, but does not affect SNP-induced endotheliumindependent relaxation[3].
IC 50
PI3Kγ: 30 nM (IC50, Neurons)
References
[1] tyagi s, sharma s, budhiraja rd. effect of phosphatidylinositol 3-kinase-γ inhibitor cay10505 in hypertension, and its associated vascular endothelium dysfunction in rats. can j physiol pharmacol. 2012 jul;90(7):881-5.
[2] sun yy, lin sh, lin hc et al. cell type-specific dependency on the pi3k/akt signaling pathway for the endogenous epo and vegf induction by baicalein in neurons versus astrocytes. plos one. 2013 jul 19;8(7):e69019.
CAY10505 Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Jinan Trio PharmaTech Co., Ltd. | 0531-88811783 | sales@trio-pharmatech.com | China | 1856 | 62 |
| Dalian Meilun Biotech Co., Ltd. | 0411-62910999 13889544652 | sales@meilune.com | China | 4765 | 58 |
| NCE Biomedical Co.,Ltd. | 4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988 | China | 1490 | 55 | |
| Haoyuan Chemexpress Co., Ltd. | 021-58950125 | info@chemexpress.com | China | 7545 | 61 |
| Shanghai Aladdin Bio-Chem Technology Co.,LTD | 400-6206333 13167063860 | anhua.mao@aladdin-e.com | China | 29985 | 65 |
| AdooQ BioScience, LLC | +1 (866) 930-6790 | info@adooq.com | United States | 2774 | 58 |
| ShangHai Caerulum Pharma Discovery Co., Ltd. | 18149758185 18149758185 | sales-cpd@caerulumpharma.com | China | 3493 | 58 |
| Bide Pharmatech Ltd. | 400-164-7117 18317119277 | product02@bidepharm.com | China | 40000 | 60 |
| AdooQ Bioscience CHINA | 025-58849295 | info@adooq.cn | China | 2981 | 60 |
| Shanghai XingMo Biotechnology Co., Ltd. | +86 13524779951; 13524779951 | 2075692521@qq.com | China | 294 | 55 |
View Lastest Price from CAY10505 manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-07-27 | CAY10505
1218777-13-9
|
$51.00-155.00 | 99.79% | 10g | TargetMol Chemicals Inc. | ||
![]() |
2019-12-23 | (5E)-5-[[5-(4-fluorophenyl)furan-2-yl]methylidene]-1,3-thiazolidine-2,4-dione
1218777-13-9
|
$1.00 | 1KG | Min98% HPLC | Career Henan Chemical Co |
-

- CAY10505
1218777-13-9
- $51.00-155.00
- 99.79%
- TargetMol Chemicals Inc.
-
![(5E)-5-[[5-(4-fluorophenyl)furan-2-yl]methylidene]-1,3-thiazolidine-2,4-dione pictures](https://img.chemicalbook.com/ProductImageEN/2019-12/Small/b05452aa-4cbb-4b66-9169-2567e3f60fce.png)
- (5E)-5-[[5-(4-fluorophenyl)furan-2-yl]methylidene]-1,3-thiazolidine-2,4-dione
1218777-13-9
- $1.00
- Min98% HPLC
- Career Henan Chemical Co




